TET2 and DNMT3A mutations in human T-cell lymphoma - PubMed (original) (raw)
TET2 and DNMT3A mutations in human T-cell lymphoma
Lucile Couronné et al. N Engl J Med. 2012.
No abstract available
Similar articles
- Double somatic mosaic mutations in TET2 and DNMT3A--origin of peripheral T cell lymphoma in a case.
Nguyen TB, Sakata-Yanagimoto M, Nakamoto-Matsubara R, Enami T, Ito Y, Kobayashi T, Obara N, Hasegawa Y, Chiba S. Nguyen TB, et al. Ann Hematol. 2015 Jul;94(7):1221-3. doi: 10.1007/s00277-015-2332-0. Epub 2015 Feb 17. Ann Hematol. 2015. PMID: 25687841 No abstract available. - Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
Ponciano-Gómez A, Martínez-Tovar A, Vela-Ojeda J, Olarte-Carrillo I, Centeno-Cruz F, Garrido E. Ponciano-Gómez A, et al. Tumour Biol. 2017 Oct;39(10):1010428317732181. doi: 10.1177/1010428317732181. Tumour Biol. 2017. PMID: 28992762 - A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
Fernandez-Pol S, Ma L, Joshi RP, Arber DA. Fernandez-Pol S, et al. Appl Immunohistochem Mol Morphol. 2019 Jul;27(6):416-422. doi: 10.1097/PAI.0000000000000644. Appl Immunohistochem Mol Morphol. 2019. PMID: 29629950 - Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma.
Fukumoto K, Nguyen TB, Chiba S, Sakata-Yanagimoto M. Fukumoto K, et al. Cancer Sci. 2018 Mar;109(3):490-496. doi: 10.1111/cas.13393. Epub 2017 Nov 27. Cancer Sci. 2018. PMID: 28889481 Free PMC article. Review. - Clinical implications of novel mutations in epigenetic modifiers in AML.
Abdel-Wahab O, Patel J, Levine RL. Abdel-Wahab O, et al. Hematol Oncol Clin North Am. 2011 Dec;25(6):1119-33. doi: 10.1016/j.hoc.2011.09.013. Epub 2011 Oct 29. Hematol Oncol Clin North Am. 2011. PMID: 22093580 Review.
Cited by
- Association of Somatic Gene Mutations with Risk of Transformation into Acute Myeloid Leukemia in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis.
Sutandyo N, Mulyasari R, Kosasih A, Rinaldi I, Louisa M, Kevinsyah AP, Winston K. Sutandyo N, et al. Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1107-1116. doi: 10.31557/APJCP.2022.23.4.1107. Asian Pac J Cancer Prev. 2022. PMID: 35485665 Free PMC article. - The Future of Combination Therapies for Peripheral T Cell Lymphoma (PTCL).
Ma H, Davarifar A, Amengual JE. Ma H, et al. Curr Hematol Malig Rep. 2018 Feb;13(1):13-24. doi: 10.1007/s11899-018-0432-3. Curr Hematol Malig Rep. 2018. PMID: 29397528 Review. - DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells.
Gu T, Lin X, Cullen SM, Luo M, Jeong M, Estecio M, Shen J, Hardikar S, Sun D, Su J, Rux D, Guzman A, Lee M, Qi LS, Chen JJ, Kyba M, Huang Y, Chen T, Li W, Goodell MA. Gu T, et al. Genome Biol. 2018 Jul 12;19(1):88. doi: 10.1186/s13059-018-1464-7. Genome Biol. 2018. PMID: 30001199 Free PMC article. - Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.
Mayle A, Yang L, Rodriguez B, Zhou T, Chang E, Curry CV, Challen GA, Li W, Wheeler D, Rebel VI, Goodell MA. Mayle A, et al. Blood. 2015 Jan 22;125(4):629-38. doi: 10.1182/blood-2014-08-594648. Blood. 2015. PMID: 25416277 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources